[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Cellular and Gene Therapy CDMO Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

October 2023 | 102 pages | ID: GC3B1B0A1B94EN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question

The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Cellular and Gene Therapy CDMO market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Cellular and Gene Therapy CDMO market are covered in Chapter 9:
Helixmith
Lonza
RoslinCT
Charles River
Cell Therapies
BIOCENTRIQ
Pharmaron
OBiO
Genezen
Oxford BioMedica
FUJIFILM Diosynth Biotechnologies
AGC Biologics
CBM
The Discovery Labs
Catalent
Cytiva
GenScript ProBio
ThermoGenesis
Exothera
Porton Pharma Solutions
Thermo Fisher Scientific
WuXi AppTec
Bio Elpida
CCRM
Anemocyte
In Chapter 5 and Chapter 7.3, based on types, the Cellular and Gene Therapy CDMO market from 2017 to 2027 is primarily split into:
Cell Therapy
Viral Vectors
Plasmid
Others
In Chapter 6 and Chapter 7.4, based on applications, the Cellular and Gene Therapy CDMO market from 2017 to 2027 covers:
Commercial
Academic Research
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Cellular and Gene Therapy CDMO market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Cellular and Gene Therapy CDMO Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 CELLULAR AND GENE THERAPY CDMO MARKET OVERVIEW

1.1 Product Overview and Scope of Cellular and Gene Therapy CDMO Market
1.2 Cellular and Gene Therapy CDMO Market Segment by Type
  1.2.1 Global Cellular and Gene Therapy CDMO Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Cellular and Gene Therapy CDMO Market Segment by Application
  1.3.1 Cellular and Gene Therapy CDMO Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Cellular and Gene Therapy CDMO Market, Region Wise (2017-2027)
  1.4.1 Global Cellular and Gene Therapy CDMO Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Cellular and Gene Therapy CDMO Market Status and Prospect (2017-2027)
  1.4.3 Europe Cellular and Gene Therapy CDMO Market Status and Prospect (2017-2027)
  1.4.4 China Cellular and Gene Therapy CDMO Market Status and Prospect (2017-2027)
  1.4.5 Japan Cellular and Gene Therapy CDMO Market Status and Prospect (2017-2027)
  1.4.6 India Cellular and Gene Therapy CDMO Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Cellular and Gene Therapy CDMO Market Status and Prospect (2017-2027)
  1.4.8 Latin America Cellular and Gene Therapy CDMO Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Cellular and Gene Therapy CDMO Market Status and Prospect (2017-2027)
1.5 Global Market Size of Cellular and Gene Therapy CDMO (2017-2027)
  1.5.1 Global Cellular and Gene Therapy CDMO Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Cellular and Gene Therapy CDMO Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Cellular and Gene Therapy CDMO Market

2 INDUSTRY OUTLOOK

2.1 Cellular and Gene Therapy CDMO Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Cellular and Gene Therapy CDMO Market Drivers Analysis
2.4 Cellular and Gene Therapy CDMO Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Cellular and Gene Therapy CDMO Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Cellular and Gene Therapy CDMO Industry Development

3 GLOBAL CELLULAR AND GENE THERAPY CDMO MARKET LANDSCAPE BY PLAYER

3.1 Global Cellular and Gene Therapy CDMO Sales Volume and Share by Player (2017-2022)
3.2 Global Cellular and Gene Therapy CDMO Revenue and Market Share by Player (2017-2022)
3.3 Global Cellular and Gene Therapy CDMO Average Price by Player (2017-2022)
3.4 Global Cellular and Gene Therapy CDMO Gross Margin by Player (2017-2022)
3.5 Cellular and Gene Therapy CDMO Market Competitive Situation and Trends
  3.5.1 Cellular and Gene Therapy CDMO Market Concentration Rate
  3.5.2 Cellular and Gene Therapy CDMO Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL CELLULAR AND GENE THERAPY CDMO SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Cellular and Gene Therapy CDMO Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Cellular and Gene Therapy CDMO Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Cellular and Gene Therapy CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Cellular and Gene Therapy CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Cellular and Gene Therapy CDMO Market Under COVID-19
4.5 Europe Cellular and Gene Therapy CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Cellular and Gene Therapy CDMO Market Under COVID-19
4.6 China Cellular and Gene Therapy CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Cellular and Gene Therapy CDMO Market Under COVID-19
4.7 Japan Cellular and Gene Therapy CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Cellular and Gene Therapy CDMO Market Under COVID-19
4.8 India Cellular and Gene Therapy CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Cellular and Gene Therapy CDMO Market Under COVID-19
4.9 Southeast Asia Cellular and Gene Therapy CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Cellular and Gene Therapy CDMO Market Under COVID-19
4.10 Latin America Cellular and Gene Therapy CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Cellular and Gene Therapy CDMO Market Under COVID-19
4.11 Middle East and Africa Cellular and Gene Therapy CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Cellular and Gene Therapy CDMO Market Under COVID-19

5 GLOBAL CELLULAR AND GENE THERAPY CDMO SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Cellular and Gene Therapy CDMO Sales Volume and Market Share by Type (2017-2022)
5.2 Global Cellular and Gene Therapy CDMO Revenue and Market Share by Type (2017-2022)
5.3 Global Cellular and Gene Therapy CDMO Price by Type (2017-2022)
5.4 Global Cellular and Gene Therapy CDMO Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Cellular and Gene Therapy CDMO Sales Volume, Revenue and Growth Rate of Cell Therapy (2017-2022)
  5.4.2 Global Cellular and Gene Therapy CDMO Sales Volume, Revenue and Growth Rate of Viral Vectors (2017-2022)
  5.4.3 Global Cellular and Gene Therapy CDMO Sales Volume, Revenue and Growth Rate of Plasmid (2017-2022)
  5.4.4 Global Cellular and Gene Therapy CDMO Sales Volume, Revenue and Growth Rate of Others (2017-2022)

6 GLOBAL CELLULAR AND GENE THERAPY CDMO MARKET ANALYSIS BY APPLICATION

6.1 Global Cellular and Gene Therapy CDMO Consumption and Market Share by Application (2017-2022)
6.2 Global Cellular and Gene Therapy CDMO Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Cellular and Gene Therapy CDMO Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Cellular and Gene Therapy CDMO Consumption and Growth Rate of Commercial (2017-2022)
  6.3.2 Global Cellular and Gene Therapy CDMO Consumption and Growth Rate of Academic Research (2017-2022)
  6.3.3 Global Cellular and Gene Therapy CDMO Consumption and Growth Rate of Others (2017-2022)

7 GLOBAL CELLULAR AND GENE THERAPY CDMO MARKET FORECAST (2022-2027)

7.1 Global Cellular and Gene Therapy CDMO Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Cellular and Gene Therapy CDMO Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Cellular and Gene Therapy CDMO Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Cellular and Gene Therapy CDMO Price and Trend Forecast (2022-2027)
7.2 Global Cellular and Gene Therapy CDMO Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Cellular and Gene Therapy CDMO Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Cellular and Gene Therapy CDMO Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Cellular and Gene Therapy CDMO Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Cellular and Gene Therapy CDMO Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Cellular and Gene Therapy CDMO Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Cellular and Gene Therapy CDMO Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Cellular and Gene Therapy CDMO Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Cellular and Gene Therapy CDMO Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Cellular and Gene Therapy CDMO Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Cellular and Gene Therapy CDMO Revenue and Growth Rate of Cell Therapy (2022-2027)
  7.3.2 Global Cellular and Gene Therapy CDMO Revenue and Growth Rate of Viral Vectors (2022-2027)
  7.3.3 Global Cellular and Gene Therapy CDMO Revenue and Growth Rate of Plasmid (2022-2027)
  7.3.4 Global Cellular and Gene Therapy CDMO Revenue and Growth Rate of Others (2022-2027)
7.4 Global Cellular and Gene Therapy CDMO Consumption Forecast by Application (2022-2027)
  7.4.1 Global Cellular and Gene Therapy CDMO Consumption Value and Growth Rate of Commercial(2022-2027)
  7.4.2 Global Cellular and Gene Therapy CDMO Consumption Value and Growth Rate of Academic Research(2022-2027)
  7.4.3 Global Cellular and Gene Therapy CDMO Consumption Value and Growth Rate of Others(2022-2027)
7.5 Cellular and Gene Therapy CDMO Market Forecast Under COVID-19

8 CELLULAR AND GENE THERAPY CDMO MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Cellular and Gene Therapy CDMO Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Cellular and Gene Therapy CDMO Analysis
8.6 Major Downstream Buyers of Cellular and Gene Therapy CDMO Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Cellular and Gene Therapy CDMO Industry

9 PLAYERS PROFILES

9.1 Helixmith
  9.1.1 Helixmith Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.1.3 Helixmith Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Lonza
  9.2.1 Lonza Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.2.3 Lonza Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 RoslinCT
  9.3.1 RoslinCT Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.3.3 RoslinCT Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Charles River
  9.4.1 Charles River Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.4.3 Charles River Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Cell Therapies
  9.5.1 Cell Therapies Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.5.3 Cell Therapies Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 BIOCENTRIQ
  9.6.1 BIOCENTRIQ Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.6.3 BIOCENTRIQ Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 Pharmaron
  9.7.1 Pharmaron Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.7.3 Pharmaron Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 OBiO
  9.8.1 OBiO Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.8.3 OBiO Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 Genezen
  9.9.1 Genezen Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.9.3 Genezen Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis
9.10 Oxford BioMedica
  9.10.1 Oxford BioMedica Basic Information, Manufacturing Base, Sales Region and Competitors
  9.10.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.10.3 Oxford BioMedica Market Performance (2017-2022)
  9.10.4 Recent Development
  9.10.5 SWOT Analysis
9.11 FUJIFILM Diosynth Biotechnologies
  9.11.1 FUJIFILM Diosynth Biotechnologies Basic Information, Manufacturing Base, Sales Region and Competitors
  9.11.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.11.3 FUJIFILM Diosynth Biotechnologies Market Performance (2017-2022)
  9.11.4 Recent Development
  9.11.5 SWOT Analysis
9.12 AGC Biologics
  9.12.1 AGC Biologics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.12.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.12.3 AGC Biologics Market Performance (2017-2022)
  9.12.4 Recent Development
  9.12.5 SWOT Analysis
9.13 CBM
  9.13.1 CBM Basic Information, Manufacturing Base, Sales Region and Competitors
  9.13.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.13.3 CBM Market Performance (2017-2022)
  9.13.4 Recent Development
  9.13.5 SWOT Analysis
9.14 The Discovery Labs
  9.14.1 The Discovery Labs Basic Information, Manufacturing Base, Sales Region and Competitors
  9.14.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.14.3 The Discovery Labs Market Performance (2017-2022)
  9.14.4 Recent Development
  9.14.5 SWOT Analysis
9.15 Catalent
  9.15.1 Catalent Basic Information, Manufacturing Base, Sales Region and Competitors
  9.15.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.15.3 Catalent Market Performance (2017-2022)
  9.15.4 Recent Development
  9.15.5 SWOT Analysis
9.16 Cytiva
  9.16.1 Cytiva Basic Information, Manufacturing Base, Sales Region and Competitors
  9.16.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.16.3 Cytiva Market Performance (2017-2022)
  9.16.4 Recent Development
  9.16.5 SWOT Analysis
9.17 GenScript ProBio
  9.17.1 GenScript ProBio Basic Information, Manufacturing Base, Sales Region and Competitors
  9.17.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.17.3 GenScript ProBio Market Performance (2017-2022)
  9.17.4 Recent Development
  9.17.5 SWOT Analysis
9.18 ThermoGenesis
  9.18.1 ThermoGenesis Basic Information, Manufacturing Base, Sales Region and Competitors
  9.18.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.18.3 ThermoGenesis Market Performance (2017-2022)
  9.18.4 Recent Development
  9.18.5 SWOT Analysis
9.19 Exothera
  9.19.1 Exothera Basic Information, Manufacturing Base, Sales Region and Competitors
  9.19.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.19.3 Exothera Market Performance (2017-2022)
  9.19.4 Recent Development
  9.19.5 SWOT Analysis
9.20 Porton Pharma Solutions
  9.20.1 Porton Pharma Solutions Basic Information, Manufacturing Base, Sales Region and Competitors
  9.20.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.20.3 Porton Pharma Solutions Market Performance (2017-2022)
  9.20.4 Recent Development
  9.20.5 SWOT Analysis
9.21 Thermo Fisher Scientific
  9.21.1 Thermo Fisher Scientific Basic Information, Manufacturing Base, Sales Region and Competitors
  9.21.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.21.3 Thermo Fisher Scientific Market Performance (2017-2022)
  9.21.4 Recent Development
  9.21.5 SWOT Analysis
9.22 WuXi AppTec
  9.22.1 WuXi AppTec Basic Information, Manufacturing Base, Sales Region and Competitors
  9.22.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.22.3 WuXi AppTec Market Performance (2017-2022)
  9.22.4 Recent Development
  9.22.5 SWOT Analysis
9.23 Bio Elpida
  9.23.1 Bio Elpida Basic Information, Manufacturing Base, Sales Region and Competitors
  9.23.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.23.3 Bio Elpida Market Performance (2017-2022)
  9.23.4 Recent Development
  9.23.5 SWOT Analysis
9.24 CCRM
  9.24.1 CCRM Basic Information, Manufacturing Base, Sales Region and Competitors
  9.24.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.24.3 CCRM Market Performance (2017-2022)
  9.24.4 Recent Development
  9.24.5 SWOT Analysis
9.25 Anemocyte
  9.25.1 Anemocyte Basic Information, Manufacturing Base, Sales Region and Competitors
  9.25.2 Cellular and Gene Therapy CDMO Product Profiles, Application and Specification
  9.25.3 Anemocyte Market Performance (2017-2022)
  9.25.4 Recent Development
  9.25.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION


11 APPENDIX

11.1 Methodology
11.2 Research Data Source

LIST OF TABLES AND FIGURES




Figure Cellular and Gene Therapy CDMO Product Picture

Table Global Cellular and Gene Therapy CDMO Market Sales Volume and CAGR (%) Comparison by Type

Table Cellular and Gene Therapy CDMO Market Consumption (Sales Volume) Comparison by Application (2017-2027)

Figure Global Cellular and Gene Therapy CDMO Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)

Figure United States Cellular and Gene Therapy CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Europe Cellular and Gene Therapy CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure China Cellular and Gene Therapy CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Japan Cellular and Gene Therapy CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure India Cellular and Gene Therapy CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Southeast Asia Cellular and Gene Therapy CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Latin America Cellular and Gene Therapy CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Middle East and Africa Cellular and Gene Therapy CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Global Cellular and Gene Therapy CDMO Market Sales Volume Status and Outlook (2017-2027)

Table Global Macroeconomic Analysis

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on Cellular and Gene Therapy CDMO Industry Development

Table Global Cellular and Gene Therapy CDMO Sales Volume by Player (2017-2022)

Table Global Cellular and Gene Therapy CDMO Sales Volume Share by Player (2017-2022)

Figure Global Cellular and Gene Therapy CDMO Sales Volume Share by Player in 2021

Table Cellular and Gene Therapy CDMO Revenue (Million USD) by Player (2017-2022)

Table Cellular and Gene Therapy CDMO Revenue Market Share by Player (2017-2022)

Table Cellular and Gene Therapy CDMO Price by Player (2017-2022)

Table Cellular and Gene Therapy CDMO Gross Margin by Player (2017-2022)

Table Mergers & Acquisitions, Expansion Plans

Table Global Cellular and Gene Therapy CDMO Sales Volume, Region Wise (2017-2022)

Table Global Cellular and Gene Therapy CDMO Sales Volume Market Share, Region Wise (2017-2022)

Figure Global Cellular and Gene Therapy CDMO Sales Volume Market Share, Region Wise (2017-2022)

Figure Global Cellular and Gene Therapy CDMO Sales Volume Market Share, Region Wise in 2021

Table Global Cellular and Gene Therapy CDMO Revenue (Million USD), Region Wise (2017-2022)

Table Global Cellular and Gene Therapy CDMO Revenue Market Share, Region Wise (2017-2022)

Figure Global Cellular and Gene Therapy CDMO Revenue Market Share, Region Wise (2017-2022)

Figure Global Cellular and Gene Therapy CDMO Revenue Market Share, Region Wise in 2021

Table Global Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table United States Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Europe Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table China Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Japan Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table India Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Southeast Asia Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Latin America Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Middle East and Africa Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Global Cellular and Gene Therapy CDMO Sales Volume by Type (2017-2022)

Table Global Cellular and Gene Therapy CDMO Sales Volume Market Share by Type (2017-2022)

Figure Global Cellular and Gene Therapy CDMO Sales Volume Market Share by Type in 2021

Table Global Cellular and Gene Therapy CDMO Revenue (Million USD) by Type (2017-2022)

Table Global Cellular and Gene Therapy CDMO Revenue Market Share by Type (2017-2022)

Figure Global Cellular and Gene Therapy CDMO Revenue Market Share by Type in 2021

Table Cellular and Gene Therapy CDMO Price by Type (2017-2022)

Figure Global Cellular and Gene Therapy CDMO Sales Volume and Growth Rate of Cell Therapy (2017-2022)
Figure Global Cellular and Gene Therapy CDMO Revenue (Million USD) and Growth Rate of Cell Therapy (2017-2022)
Figure Global Cellular and Gene Therapy CDMO Sales Volume and Growth Rate of Viral Vectors (2017-2022)
Figure Global Cellular and Gene Therapy CDMO Revenue (Million USD) and Growth Rate of Viral Vectors (2017-2022)
Figure Global Cellular and Gene Therapy CDMO Sales Volume and Growth Rate of Plasmid (2017-2022)
Figure Global Cellular and Gene Therapy CDMO Revenue (Million USD) and Growth Rate of Plasmid (2017-2022)
Figure Global Cellular and Gene Therapy CDMO Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Cellular and Gene Therapy CDMO Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Cellular and Gene Therapy CDMO Consumption by Application (2017-2022)

Table Global Cellular and Gene Therapy CDMO Consumption Market Share by Application (2017-2022)

Table Global Cellular and Gene Therapy CDMO Consumption Revenue (Million USD) by Application (2017-2022)

Table Global Cellular and Gene Therapy CDMO Consumption Revenue Market Share by Application (2017-2022)

Table Global Cellular and Gene Therapy CDMO Consumption and Growth Rate of Commercial (2017-2022)
Table Global Cellular and Gene Therapy CDMO Consumption and Growth Rate of Academic Research (2017-2022)
Table Global Cellular and Gene Therapy CDMO Consumption and Growth Rate of Others (2017-2022)
Figure Global Cellular and Gene Therapy CDMO Sales Volume and Growth Rate Forecast (2022-2027)

Figure Global Cellular and Gene Therapy CDMO Revenue (Million USD) and Growth Rate Forecast (2022-2027)

Figure Global Cellular and Gene Therapy CDMO Price and Trend Forecast (2022-2027)

Figure USA Cellular and Gene Therapy CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure USA Cellular and Gene Therapy CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Europe Cellular and Gene Therapy CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Europe Cellular and Gene Therapy CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure China Cellular and Gene Therapy CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure China Cellular and Gene Therapy CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Japan Cellular and Gene Therapy CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Japan Cellular and Gene Therapy CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure India Cellular and Gene Therapy CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure India Cellular and Gene Therapy CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia Cellular and Gene Therapy CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia Cellular and Gene Therapy CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America Cellular and Gene Therapy CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America Cellular and Gene Therapy CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa Cellular and Gene Therapy CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa Cellular and Gene Therapy CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Table Global Cellular and Gene Therapy CDMO Market Sales Volume Forecast, by Type

Table Global Cellular and Gene Therapy CDMO Sales Volume Market Share Forecast, by Type

Table Global Cellular and Gene Therapy CDMO Market Revenue (Million USD) Forecast, by Type

Table Global Cellular and Gene Therapy CDMO Revenue Market Share Forecast, by Type

Table Global Cellular and Gene Therapy CDMO Price Forecast, by Type

Figure Global Cellular and Gene Therapy CDMO Revenue (Million USD) and Growth Rate of Cell Therapy (2022-2027)
Figure Global Cellular and Gene Therapy CDMO Revenue (Million USD) and Growth Rate of Cell Therapy (2022-2027)
Figure Global Cellular and Gene Therapy CDMO Revenue (Million USD) and Growth Rate of Viral Vectors (2022-2027)
Figure Global Cellular and Gene Therapy CDMO Revenue (Million USD) and Growth Rate of Viral Vectors (2022-2027)
Figure Global Cellular and Gene Therapy CDMO Revenue (Million USD) and Growth Rate of Plasmid (2022-2027)
Figure Global Cellular and Gene Therapy CDMO Revenue (Million USD) and Growth Rate of Plasmid (2022-2027)
Figure Global Cellular and Gene Therapy CDMO Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Cellular and Gene Therapy CDMO Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Cellular and Gene Therapy CDMO Market Consumption Forecast, by Application

Table Global Cellular and Gene Therapy CDMO Consumption Market Share Forecast, by Application

Table Global Cellular and Gene Therapy CDMO Market Revenue (Million USD) Forecast, by Application

Table Global Cellular and Gene Therapy CDMO Revenue Market Share Forecast, by Application

Figure Global Cellular and Gene Therapy CDMO Consumption Value (Million USD) and Growth Rate of Commercial (2022-2027)
Figure Global Cellular and Gene Therapy CDMO Consumption Value (Million USD) and Growth Rate of Academic Research (2022-2027)
Figure Global Cellular and Gene Therapy CDMO Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Cellular and Gene Therapy CDMO Industrial Chain Analysis

Table Key Raw Materials Suppliers and Price Analysis

Figure Manufacturing Cost Structure Analysis

Table Alternative Product Analysis

Table Downstream Distributors

Table Downstream Buyers

Table Helixmith Profile
Table Helixmith Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Helixmith Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure Helixmith Revenue (Million USD) Market Share 2017-2022
Table Lonza Profile
Table Lonza Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Lonza Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure Lonza Revenue (Million USD) Market Share 2017-2022
Table RoslinCT Profile
Table RoslinCT Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure RoslinCT Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure RoslinCT Revenue (Million USD) Market Share 2017-2022
Table Charles River Profile
Table Charles River Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Charles River Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure Charles River Revenue (Million USD) Market Share 2017-2022
Table Cell Therapies Profile
Table Cell Therapies Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cell Therapies Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure Cell Therapies Revenue (Million USD) Market Share 2017-2022
Table BIOCENTRIQ Profile
Table BIOCENTRIQ Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure BIOCENTRIQ Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure BIOCENTRIQ Revenue (Million USD) Market Share 2017-2022
Table Pharmaron Profile
Table Pharmaron Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pharmaron Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure Pharmaron Revenue (Million USD) Market Share 2017-2022
Table OBiO Profile
Table OBiO Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure OBiO Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure OBiO Revenue (Million USD) Market Share 2017-2022
Table Genezen Profile
Table Genezen Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Genezen Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure Genezen Revenue (Million USD) Market Share 2017-2022
Table Oxford BioMedica Profile
Table Oxford BioMedica Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Oxford BioMedica Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure Oxford BioMedica Revenue (Million USD) Market Share 2017-2022
Table FUJIFILM Diosynth Biotechnologies Profile
Table FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure FUJIFILM Diosynth Biotechnologies Revenue (Million USD) Market Share 2017-2022
Table AGC Biologics Profile
Table AGC Biologics Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AGC Biologics Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure AGC Biologics Revenue (Million USD) Market Share 2017-2022
Table CBM Profile
Table CBM Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure CBM Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure CBM Revenue (Million USD) Market Share 2017-2022
Table The Discovery Labs Profile
Table The Discovery Labs Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure The Discovery Labs Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure The Discovery Labs Revenue (Million USD) Market Share 2017-2022
Table Catalent Profile
Table Catalent Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Catalent Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure Catalent Revenue (Million USD) Market Share 2017-2022
Table Cytiva Profile
Table Cytiva Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cytiva Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure Cytiva Revenue (Million USD) Market Share 2017-2022
Table GenScript ProBio Profile
Table GenScript ProBio Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GenScript ProBio Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure GenScript ProBio Revenue (Million USD) Market Share 2017-2022
Table ThermoGenesis Profile
Table ThermoGenesis Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure ThermoGenesis Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure ThermoGenesis Revenue (Million USD) Market Share 2017-2022
Table Exothera Profile
Table Exothera Cellular and Gene Therapy CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Exothera Cellular and Gene Therapy CDMO Sales Volume and Growth Rate
Figure Exothera Revenue (Million USD) Market Share 2017-2022
Table Porton Pharma Solutions Profile
Table Porton Pharma Solutions Cellular and Gene Therapy CDMO Sales Volume, Re


More Publications